News

How the hepatitis B virus establishes persistent infection

New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao Guo of the Indiana University School of Medicine, Bin Wang and Jiming Zhang of Fudan University, and colleagues. The findings potentially explain how the hepatitis B virus (HBV) establishes and maintains chronic infection, and could lead to the development of novel therapeutic strategies.

advertisement

The researchers analyzed the circulation frequency of MDSCs in 164 patients with chronic HBV infection and 70 healthy donors. They found that the frequency of circulating MDSCs in HBeAg-positive patients is higher than in HBeAg-negative patients. Moreover, HBeAg induced the expansion of MDSCs through the upregulation of a molecule called indoleamine-2, 3-dioxygenase (IDO), which plays a critical role in the suppression of T-cell proliferation. According to the authors, the findings suggest a novel mechanism in which HBeAg-induced MDSC expansion impairs T-cell function through the IDO pathway and favors the establishment of persistent HBV infection. The HBeAg-MDSC-IDO axis may therefore serve as an immunotherapeutic target of chronic hepatitis B.

The authors add, "HBV has may tricks to mess up the host immune system for maintaining a persistent infection, HBeAg is one of the culprits. Breaking the HBeAg-IDO-MDSC nexus may hold promise for developing new HBV therapeutics to treat HBeAg-positive patients."

advertisement

Materials provided by PLOS . Note: Content may be edited for style and length.

PLOS. "How the hepatitis B virus establishes persistent infection." ScienceDaily. ScienceDaily, 18 April 2019. .

PLOS. "How the hepatitis B virus establishes persistent infection." ScienceDaily. www.sciencedaily.com/releases/2019/04/190418145235.htm (accessed April 18, 2019).
Read more on sciencedaily.com
News Topics :
RELATED STORIES :
Science
Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B HBV and delta virus...
Science
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent...
Science
Close A new study from The Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis scarring in chronic hepatitis C patients. This finding is a...
Science
Tumors and certain viral infections pose a challenge to the human body which the immune system typically fails to hand. In these diseases it switches to hypofunctional state that prevent...
Science
Unlike its viral cousins hepatitis A and B, hepatitis C virus HCV has eluded the development of a vaccine and infected more than 170 million people worldwide. Now, researchers at...